Dosage and composition of bioactive glasses differentially regulate angiogenic and osteogenic response of human MSCs. Issue 11 (3rd October 2018)

• Record Type: Journal Article
• Authors: Qazi, Taimoor H.; Berkmann, Julia C.; Schoon, Janosch; Geißler, Sven; Duda, Georg N.; Boccaccini, Aldo R.; Lippens, Evi
• Is Part Of: Journal of biomedical materials research. Volume 106:Issue 11(2018)
• Page Start: 2827
• Page End: 2837
• Publication Date: 2018-10-03
• Subjects: bioactive glasses -- bone tissue engineering -- angiogenesis -- paracrine signaling -- mineralized matrix; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1002/jbm.a.36470
• Languages: English
• ISSNs: 1549-3296

Abstract

Abstract: Vascularization of the fracture site and cell‐mediated deposition of the mineralized matrix are crucial determinants for successful bone regeneration after injury. Ceramic biomaterials such as bioactive glasses (BAGs) that release bioactive ions have shown promising results in bone defect regeneration. However, it remains unclear how the dosage and composition of bioactive ions influence the angiogenic and osteogenic behavior of primary human mesenchymal stromal cells (MSCs). Here, we show that exposure to ionic dissolution products from 1393 and 45S5 BAGs can evoke distinct angiogenic and osteogenic responses from primary MSCs in a dose‐ and composition‐dependent manner. Significantly higher concentrations of the pro‐angiogenic factors VEGF, HGF, PIGF, angiopoietin, and angiogenin were detected in conditioned media (CM) from MSCs exposed to 45S5, but not 1393, BAGs. Application of this CM to human umbilical vein endothelial cells (HUVECs) resulted in robust 2D tube formation in vitro . Osteogenic differentiation of MSCs was assessed by gene expression analysis and mineralization assays. Low concentrations (0.1% w/v) of 1393 BAGs significantly enhanced the gene expression of RUNX2 and ALP and induced an earlier onset of matrix mineralization compared to all other groups. We further tested whether simultaneous exposure to both BAGs would improve both angiogenic secretion and osteogenic differentiation of MSCs, and did not find evidence to support this hypothesis. Our results provide evidence of BAG composition‐dependent enhancement of primary human MSCs' regenerative function, besides also underlining the importance of an in vitro evaluation of the dose–response relationship to translate BAG based approaches into safe and effective clinical therapies. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 2827–2837, 2018., 2018